Recombinant Human SEPHS2 Protein，His

SEPHS2 (Serine Hydroxymethyltransferase 2) is a key enzyme involved in the one-carbon metabolic pathway, which plays a crucial role in cellular processes such as nucleotide synthesis and amino acid metabolism. The enzyme catalyzes the conversion of serine to glycine, alongside the transfer of a hydroxymethyl group to tetrahydrofolate, thereby participating in the generation of crucial one-carbon units necessary for the biosynthesis of purines and thymidine. Research on SEPHS2 has gained attention due to its potential implications in various biological contexts, including cell proliferation, differentiation, and the pathogenesis of diseases such as cancer. Abnormal expression or activity of SEPHS2 has been linked to altered metabolic states in several cancers, underscoring the importance of understanding its structure and function. Furthermore, the exploration of SEPHS2 as a potential therapeutic target has been spurred by its pivotal role in cancer metabolism. In this context, the expression and characterization of recombinant SEPHS2 proteins are essential for elucidating its enzymatic mechanisms, substrate specificity, and interactions with other proteins and metabolites. By utilizing recombinant DNA technology to produce SEPHS2 in heterologous systems, researchers can generate sufficient quantities of the enzyme for detailed biochemical studies. These efforts will contribute significantly to our understanding of the functional dynamics of SEPHS2, helping to unravel its contributions to metabolic regulation and disease processes, ultimately paving the way for novel therapeutic strategies targeting metabolic pathways associated with this enzyme.